Showing results (51-60 of 280) with videos related to

Sort By:
Pageof 28
Cancer Immunology Research|May 7, 2015
Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage ImmunotherapyDaniel J George, Chadi Nabhan, Todd DeVries, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
All Men Are Created Equal: Addressing Disparities in Prostate Cancer CareHala Borno, Daniel J George, Lowell E Schnipper, et al.
Clinical Genitourinary Cancer|February 10, 2026
Outcomes for Patients With SPOP Mutated Castration-Resistant Prostate Cancer (CRPC) Treated With an Androgen Receptor Pathway Inhibitor (ARPI)Joseph J Park, Lauren E Howard, Stamatina Fragkogianni, et al.
Clinical Genitourinary Cancer|March 16, 2015
Deferred systemic therapy in patients with metastatic renal cell carcinomaAaron P Mitchell, Bradford R Hirsch, Michael R Harrison, et al.
JCO Oncology Practice|February 7, 2025
Real-World Evidence of Combination Therapy Use in Metastatic Hormone-Sensitive Prostate Cancer in the United States From 2017 to 2023Amit D Raval, Orsolya Lunacsek, Matthew J Korn, et al.
Angewandte Chemie (International Ed. in English)|July 20, 2018
Leveraging γ-Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer CellsSubha Bakthavatsalam, Mark L Sleeper, Azim Dharani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 2, 2026
Improving outcomes of patients with advanced prostate cancer through a better understanding of clinical factors contributing to financial toxicity: a qualitative studyEbunoluwa Olunuga, Jeremy Kurnot, Samantha Zhu, et al.
Urologic Oncology|January 18, 2015
Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancerRhonda L Bitting, Patrick Healy, Susan Halabi, et al.
Health Policy OPEN|February 6, 2026
Price transparency & out-of-pocket payments for medications: Implications of associated delivery fees in the United StatesDeborah R Kaye, Hui-Jie Lee, Daniel J George, et al.
Clinical Genitourinary Cancer|July 16, 2015
A Single-Arm Phase 1b Study of Everolimus and Sunitinib in Patients With Advanced Renal Cell CarcinomaRavindran Kanesvaran, Kevin Watt, James D Turnbull, et al.
Pageof 28